Knöller S M, Brieschal T
Department für Orthopädie und Traumatologie, Klinik für Orthopädie des Klinikums der Albert-Ludwigs-Universität Freiburg.
Z Orthop Ihre Grenzgeb. 2004 Jan-Feb;142(1):109-14. doi: 10.1055/s-2004-817658.
The risk of transmission of human immunodeficiency virus (HIV), hepatitis B and C viruses as well as the development of costs has changed the use of homologous blood cell products.
The present investigation shows the state of the art of blood salvage in orthopedic and elective trauma surgery.
In this investigation the established methods such as controlled hypotension (spine surgery), arrest of blood supply (extremity surgery) and the following methods of autotransfusion have been examined: acute normovolemic hemodilution (ANH), intra- (Cell-Saver, Haemonetics Corp.) and postoperative autotransfusion, autologous donor plasmapheresis and autologous predeposit.
Using this method it is possible to reduce homologous blood transfusions particularly in elective procedures such as orthopedic surgery and elective trauma surgery to a minimum.
人类免疫缺陷病毒（HIV）、乙型和丙型肝炎病毒传播风险以及成本的变化改变了同源血细胞制品的使用情况。
本调查展示了骨科和择期创伤手术中血液回收的现状。
在本次调查中，对诸如控制性低血压（脊柱手术）、血供阻断（肢体手术）等既定方法以及以下自体输血方法进行了研究：急性等容血液稀释（ANH）、术中（细胞回收机，Haemonetics公司）及术后自体输血、自体供者血浆置换和自体预存。
采用这种方法可将同源输血尤其是在骨科手术和择期创伤手术等择期手术中的使用降至最低。
